Back to Journals » Lung Cancer: Targets and Therapy » Volume 2

Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer

Total article views   HTML views PDF downloads Totals
14,228 Dovepress* 12,894+ 5,028 17,922
PubMed Central* 1,334 189 1,523
Totals 14,228 5,217 19,445
*Since 14 October 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 0 5

View citations on PubMed Central and Google Scholar